Roche launches the AVENIO Edge System to simplify and automate next-generation sequencing sample preparation, reduce human error and advance precision medicine

Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare Preparing DNA for sequencing libraries is complex and prone to human error, which can interfere with accurate sequencing results The new AVENIO Edge System is a fully-automated solution for the sample preparation workflow, from DNA... Read more

Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19

EMA’s CHMP recommended the approval yesterday Approval based on results from four phase III studies in over 5,500 patients Actemra/RoActemra has also been provisionally approved in Australia for the treatment of COVID-19 Basel, 07 December 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has extended the marketing authorisation for... Read more

Sir Martin Wood, 1927 -2021

24 November 2021 Oxford Instruments was saddened to learn of the death of our founder, Sir Martin Wood, 94, on 23 November after a short illness. We offer our sincere condolences to his wife Audrey, and their extended family, during this difficult time. Oxford Instruments was started in Martin and Audrey’s garden shed in 1959.... Read more

Roche launches cobas 5800, a new molecular diagnostics system to expand access to testing and improve patient care

Infectious diseases, such as those infections transmitted via respiratory, sexually and transplant, are becoming increasingly difficult to manage and represent an ever-growing medical need for millions of patients worldwide. Access to accurate and reliable diagnostic tests help clinicians improve patient care, limit healthcare spending and contribute to protecting public health. The cobas 5800 System is... Read more

Brooks Automation Reports Results of Fourth Quarter of Fiscal 2021, Ended September 30, 2021, and Announces Quarterly Cash Dividend

Brooks Automation Reports Results of Fourth Quarter of Fiscal 2021, Ended September 30, 2021, and Announces Quarterly Cash Dividend Strong Double-Digit Growth Quarter Underscores Robust Demand Environment in Life Sciences CHELMSFORD, Mass., Nov. 10, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the fiscal quarter ended September 30, 2021. Summary of... Read more

New IVD System Enables Assay Developers and Clinical Laboratories to Accelerate Molecular Diagnostics Growth

New IVD System Enables Assay Developers and Clinical Laboratories to Accelerate Molecular Diagnostics Growth Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow CARLSBAD, Calif., Nov. 9, 2021 /PRNewswire/ — As assay developers and clinical testing laboratories consider next steps for molecular diagnostics post-pandemic, a new in vitro diagnostic (IVD)... Read more